Sign Up | Log In | What is SocialPicks?

Antigenics Inc. (AGEN) Trade Now » Rate AGEN - Discuss AGEN - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

86.5%

Top:

0.0%

Rate AGEN:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

AGEN: Bull or Bear?

From: SocialPicks | Blogsphere | All

From the Blogosphere

This Week's Insider Buys

2 %

Ruby Tuesday Inc (RT)= $4,399,115
Smithfield Foods Inc (SFD)= $4,180,220
Antigenics Inc De (AGEN)= $ 3,912,969
Zhongpin Inc (HOGS)= $ 3,901,573
Hovnanian Enterprises Inc (HOV)= $ 2,060,639
Cheniere Energy Inc (LNG)= $1,830,000
Shoretel Inc (SHOR)= $ 1,278,979
American Capital Strategies Ltd (ACAS)= $1,275,289
Xtl Biopharmaceuticals Ltd (XTLB)= $ 1,262,070
Stein Mart Inc (SMRT)= $1,143,441
Iomega Corp (IOM)= $ 1,111,895

? Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Continue reading »

By Todd Sullivan (-25.49% risk: aggressive) 01/19/08

Comment

This Week's Insider Buys

? Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Continue reading »

By Todd Sullivan (+0.00%) 01/19/08

Comment

« previous
1
2
3
4
5
« next

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
C	Citigroup Inc
WFC	Wells Fargo & Company
IBM	International Business Machines Corp
PFE	Pfizer Inc
JNJ	Johnson & Johnson
GS	Goldman Sachs Group Inc The

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

StreetInsider.com on AGEN

Visit streetinsider.com

Discussion Wall

+ Add

amritadas (+0.00%)

A FREE report on the approval of a new Gout Drug - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...

+	0 replies

... more »

More Resources

About Antigenics Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.